Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 62 (Supplement) , 45-52
- https://doi.org/10.2165/00003495-200262002-00005
Abstract
Sustained-release bupropion (bupropion SR) was first launched in the US in 1997 as an aid to smoking cessation and has since been launched in many other countries. Adverse events associated with the...Keywords
This publication has 20 references indexed in Scilit:
- Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking CessationAnnals of Internal Medicine, 2001
- Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled studyClinical Pharmacology & Therapeutics, 2001
- Bupropion‐induced hypersensitivity reactionsThe Medical Journal of Australia, 2001
- Serum Sickness-like Reaction With BupropionJAMA, 1999
- Bupropion hydrochloride induced serum sickness-like reactionAnnals of Allergy, Asthma & Immunology, 1999
- Development of Depression During Placebo-Controlled Trials of Bupropion for Smoking CessationThe Journal of Clinical Psychiatry, 1999
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- A Comparison of Sustained-Release Bupropion and Placebo for Smoking CessationNew England Journal of Medicine, 1997
- Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.BMJ, 1993
- Cardiovascular effects of bupropion in depressed patients with heart diseaseAmerican Journal of Psychiatry, 1991